Detection of Alzheimer's amyloid beta aggregation by capturing molecular trails of individual assemblies

Biochemical and Biophysical Research Communications

Volumn 377, Issue 2, 2008, Pages 725-728

  Vestergaard, Mun'delanji ^a   Hamada, Tsutomu ^a   Saito, Masato ^b   Yajima, Yoshifumi ^a   Kudou, Monotori ^c   Tamiya, Eiichi ^b   Takagi, Masahiro ^a  

^a JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aggregation; Alzheimer's disease (AD); Amyloid beta; Brownian motion; Fluorescence microscopy; Hydrodynamic radius (RH); Molecular trails; Oligomerisation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; METAL ION;

ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; ELECTROCHEMISTRY; FLUORESCENCE MICROSCOPY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; QUANTITATIVE ANALYSIS; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; PROTEIN FOLDING;

EID: 55549108666     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.072     Document Type: Article

References (28)

1. Stine Jr. W.B., Dahigren K.N., Krafft G.A., and LaDu M.J. In vitro characterisation of conditions for amyloid-β peptide oligomerisation and fibrillogenesis. J. Biol. Chem. 278 (2003) 11612-11622
2. Shen C.L., and Murphy R.M. Solvent effects on self-assembly of beta-amyloid peptide. Biophys. J. 69 (1995) 640-651
3. Lippa C.F., Nee L.E., Mori H., and George-Hyslop P. Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease. Lancet 352 (1998) 1117-1118
4. Asami-Odaka A., Ishibashi Y., Kikuchi T., Kitada C., and Suzuki N. Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry 34 (1995) 10272-10278
5. Jarrett J., Berger E., and Lansbury P. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32 (1993) 4693-4697
6. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (2006) 184-185
7. Lesne S., Toh M.T., Kotlinek L., Kayed R., Glabe C.G., and Yang A. A specific amyloid-β assembly in the brain impairs memory. Nature 440 (2006) 353-357
8. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
9. Naslund J., Harautunian V., Mohs R., Davis K.L., Davies P., Greengard P., and Bauxbaum J.D. Correlation between elevated levels of amyloid-β-peptide in the brain and cognitive decline. J. Am. Med. Ass. 283 (2000) 1571-1577
10. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., and Rogers J. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155 (1999) 853-862
11. Szabo Z., Klement E., Jost K., Zarandi M., Soos K., and Penke B. An FT-IR study of the β-amyloid conformation: standardisation of aggregation grade. Biochem. Biophys. Res. Commun. 265 (1999) 297-300
12. Ono K., Yoshiike Y., Takashima A., Hasewaga K., Naiki H., and Yamada J. Peptide anti-amyloidogenic and fibril-destabilising effects of polyphenols in vitro: implications for the prevention an therapeutics of Alzheimer's disease. Neurochem 87 (2003) 172-181
13. Yoshiike Y., Tanemura K., Murayama O., Akagi T., Murayama M., Sata S., Sun X., Tanaka N., and Takashima A. New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity. J. Biol. Chem. 276 (2001) 32293-322999
14. Klunk W.E., Wang Y., Huang G.F., Debnath M.L., Holt D.P., and Mathis C.A. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 69 (2001) 1471-1484
15. Klunk W.E., Wang Y., Huang G., Debnath M.L., Holt D.P., Shao L., Hamilton R.L., Ikonomovic M.D., DeKosky S.T., and Mathis C.A. The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J. Neurosci. 23 (2003) 2086-2092
16. Vestergaard M., Kerman K., Masato S., Nagatani N., Takamura Y., and Tamiya E. E. A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid beta aggregation. J. Am. Chem. Soc. 127 (2005) 11892-11893
17. Wang S.S., Becarra-Arteaga A., and Good T.A. Development of a novel difusion-based method to estimate the size of the aggregated Aβ species responsible for neurotoxicity. J. Biotech. Bioeng. 18 (2002) 50-59
18. Yong W., Lomakin A., Kirkitadze M.D., Teplow D.B., and Chen S.-H. Structure determination of micelle-like intermediates in amyloid beta-protein fibril assembly by using small angle neutron scattering. Proc. Natl. Acad. Sci. USA 99 (2002) 150-154
19. Carrotta R., Manno M., Bulone D., Martorana V., and SanBiagio P.L. Protofibril formation of amyloid β-protein at low pH via a non-cooperative elongation mechanism. J. Biol. Chem. 280 (2005) 30001-30008
20. Sato Y.T., Hamada T., Kubo K., Yamada A., Kishida T., Mazda O., and Yoshikawa K. Folding transition into loosely collapsed state in plasmid DNA as revealed by single-molecule observation. FEBS 579 (2005) 3095-3099
21. Matsumoto M., Sakaguchi T., Kimura H., Doi M., Minagawa K., Matsuzawa Y., and Yoshikawa K. Direct observation of Brownian motion of macromolecules by fluorescence microscope. J. Polym. Sci. B Polym. Phys. 30 (1992) 783-799
22. Sengupta P., Garai K., Sahoo B., Shi Y., Callaway D.J.E., and Maiti S. The amyloid beta peptide (Abeta(1-40)) is thermodynamically soluble at physiological concentrations. Biochemistry 42 (2003) 10506-10513
23. Chen Y.R., and Glabe C.G. Distinct early folding and aggregation properties of Alzheimer amyloid-β peptides Aβ40 and Aβ42. J. Biol. Chem. 281 (2006) 24414-24422
24. Bitan G., Lomakin A., and Teplow D.B. Amyloid β-protein oligomerisation, prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276 (2001) 35176-35184
25. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., and Teplow D.W. Amyloid beta-protein (Abeta) assembly: AB 40 and Abeta 42 oligomerise through distinct pathways. Proc. Natl. Acad. Sci. USA 100 (2003) 330-335
26. Moss M.A., Nichols M.R., Reed D.K., Hoh J.H., and Rosenberry T.L. The peptide KLVFF-K(6) promotes beta-amyloid (1-40) protofibril growth by association but does not alter protofibril effects on cellular reduction of 3-(4,5-dimethylthiazol-2-ul)-2,5-diphenyltetrazolium bromide (MTT). Mol. Pharmacol. 64 (2003) 1160-1168
27. Bateman D.A., JoAnne McLaurin J., and Chakrabartty A. Requirement of aggregation propensity of Alzheimer's amyloid peptides for neuronal cell surface binding. BMC Neuroscience 8 (2007) 29
28. Vestergaard M., Hamada T., and Takagi M. Using model membranes for the study of amyloid beta:lipid interactions and neurotoxicity. J. Biotech. Bioeng. 99 (2008) 753-763